What is the harm-benefit ratio of Cox-2 inhibitors?

T.P. van Staa; L. Smeeth; I. Persson; J. Parkinson; H.G.M. Leufkens

What is the harm-benefit ratio of Cox-2 inhibitors?

T.P. van Staa, L. Smeeth, I. Persson, J. Parkinson, H.G.M. Leufkens

Dep Farmaceutische wetenschappen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	405-413
Number of pages	9
Journal	International Journal of Epidemiology
Volume	17
Publication status	Published - 2008

Keywords

Epidemiology
Farmacie(FARM)
Biomedische technologie en medicijnen
Ziekenhuisstructuur en organisatie van de gezondheidszorg
Public Health

Cite this

@article{df174e2453dd4e059426d8bfe586787e,

title = "What is the harm-benefit ratio of Cox-2 inhibitors?",

keywords = "Epidemiology, Farmacie(FARM), Biomedische technologie en medicijnen, Ziekenhuisstructuur en organisatie van de gezondheidszorg, Public Health",

author = "{van Staa}, T.P. and L. Smeeth and I. Persson and J. Parkinson and H.G.M. Leufkens",

year = "2008",

language = "Undefined/Unknown",

volume = "17",

pages = "405--413",

journal = "International Journal of Epidemiology",